NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
13.98
+0.99 (7.62%)
Jan 7, 2026, 4:00 PM EST - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $49.01 million as of January 8, 2026. Its market cap has increased by 96.62% in one year.
Market Cap
49.01M
Enterprise Value
25.29M
1-Year Change
96.62%
Ranking
Category
Stock Price
$13.98
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $49.01M, a decrease of -88.77%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 45.54M | -8.46% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |